Delivery Order SPE2DB20D3304-SPE2DB24FW6N3

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564767676 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,212.51 and a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,482.56 firm fixed-price delivery order is for the supply of 4564886122 - LIDOCAINE 5% PATCH 30S, with a completion date of June 13, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,851.57 firm fixed-price Delivery Order is for the supply of 4564949989 - LIDOCAINE 5% PATCH 30S, with a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,366.03 firm fixed price delivery order was awarded on July 11, 2024 with a completion date of July 12, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,026.81 for the supply of 4563927893 - LIDOCAINE 5% PATCH 30S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this firm fixed price contract, which is not designated...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DX15D3306|SPE2DX25FADMG) valued at $2,237.95. The award is for the supply of LIDOCAINE 5% PATCH 30S medical products. The contract has a firm fixed price and an ultimate completion date of November 18, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,184.98 contract is for the supply of 4564358079 - LIDOCAINE 5% PATCH 30S. It is a firm-fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen is a major pharmaceutical distribution company that provides a wide range of medical products and supplies to various government agencies, including the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,623.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4563866262 LIDOCAINE 5% PATCH 30S. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $9,102.72 for the supply of LIDOCAINE 5% PATCH 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has an ultimate completion date of June 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $14,800.21 firm fixed price delivery order contract for the supply of 4563471940 - LIDOCAINE 5% PATCH 30S. This delivery order contract has a period of performance through January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6N3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,483.57 for the supply of 4564983454 LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order does not have a set-aside designation.

Generated 9/23/24, 9:45 AM